Myriad Genetics, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6912
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Myriad Genetics, Inc. (Myriad or ‘the company’) is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. The company operates a CLIA-certified laboratory facility in Salt Lake City, Utah to perform most of the molecular diagnostic tests; a CLIA-certified laboratory in South San Francisco, California; a single laboratory facility in Munich, Germany to perform the international molecular diagnostic tests; and a CLIA-certified laboratory facility in Austin, Texas. The company has its operations in the US and Europe. Myriad is headquartered in Salt Lake City, Utah.

Scope

- Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Myriad Genetics, Inc. including a breakdown and examination of key business segments
- Intelligence on Myriad Genetics, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Myriad Genetics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Myriad Genetics, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Myriad Genetics, Inc.: Company Overview 9
Myriad Genetics, Inc.: Overview and Key Facts 9
Myriad Genetics, Inc.: Overview 9
Myriad Genetics, Inc.: Key Facts 9
Myriad Genetics, Inc.: Key Employees 10
Myriad Genetics, Inc.: Key Employee Biographies 12
Myriad Genetics, Inc.: Major Products and Services 18
Myriad Genetics, Inc.: Company History 19
Myriad Genetics, Inc.: Management Statement 23
Myriad Genetics, Inc.: Locations and Subsidiaries 26
Myriad Genetics, Inc.: Key Competitors 27
Myriad Genetics, Inc.: Company Analysis 28
Myriad Genetics, Inc.: Business Description 28
Myriad Genetics, Inc.: SWOT Analysis 29
Myriad Genetics, Inc.: SWOT Overview 29
Myriad Genetics, Inc.: Strengths 29
Myriad Genetics, Inc.: Weaknesses 31
Myriad Genetics, Inc.: Opportunities 31
Myriad Genetics, Inc.: Threats 32
Myriad Genetics, Inc.: Corporate Financial Deals Activity 34
Myriad Genetics, Inc.: Financial Deals Overview 34
Myriad Genetics, Inc.: Targets and Partners 36
Myriad Genetics, Inc.: Top Deals 2014 – 2018YTD* 37
Myriad Genetics, Inc.: Advisors 38
Myriad Genetics, Inc.: Top Legal Advisors 38
Myriad Genetics, Inc.: Top Financial Advisors 38
Myriad Genetics, Inc.: Mergers and Acquisitions 39
Myriad Genetics, Inc.: Capital Raising 40
Myriad Genetics, Inc.: Partnership 41
Myriad Genetics, Inc.: Recent Developments 42
Myriad Genetics, Inc.: News and Events Summary 42
Myriad Genetics, Inc.: Business Expansion 45
Myriad Genetics, Inc.: Contracts 45
Myriad Genetics, Inc.: Financial Performance 46
Myriad Genetics, Inc.: Market Developments 47
Myriad Genetics, Inc.: Regulatory and Legal Events 47
Myriad Genetics, Inc.: Research & Development 48
Myriad Genetics, Inc.: Strategy and Operations 49
Appendix 50
Contact Us 50
Methodology 50
About MarketLine 51

List of Tables
Table 1: Myriad Genetics, Inc.: Key Facts
Table 2: Myriad Genetics, Inc.: Key Employees
Table 3: Myriad Genetics, Inc.: Company History
Table 4: Myriad Genetics, Inc.: Locations and Subsidiaries
Table 5: Myriad Genetics, Inc.: Key Competitors
Table 6: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Myriad Genetics, Inc.: M&A Activity by Geography (TTM*)
Table 8: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Myriad Genetics, Inc.: M&A Average Deal Size - Value (US$m)
Table 10: Myriad Genetics, Inc.: Targets and Partners
Table 11: Myriad Genetics, Inc.: Top Deals 2014 - 2018YTD*
Table 12: Myriad Genetics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 13: Myriad Genetics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 14: Myriad Genetics, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 15: Myriad Genetics, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 16: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 17: Myriad Genetics, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 18: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 19: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 20: Myriad Genetics, Inc.: News and Events Summary
Table 21: Myriad Genetics, Inc.: Business Expansion
Table 22: Myriad Genetics, Inc.: Contracts
Table 23: Myriad Genetics, Inc.: Financial Performance
Table 24: Myriad Genetics, Inc.: Market Developments
Table 25: Myriad Genetics, Inc.: Regulatory and Legal Events
Table 26: Myriad Genetics, Inc.: Research & Development
Table 27: Myriad Genetics, Inc.: Strategy and Operations

List of Figures
Figure 1: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Myriad Genetics, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Myriad Genetics, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Myriad Genetics, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Myriad Genetics, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Myriad Genetics, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 9: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Myriad Genetics, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Maruti Suzuki India Limited:企業の戦略・SWOT・財務情報
    Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report Summary Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Exxon Mobil Corp (XOM):企業の財務・戦略的SWOT分析
    Exxon Mobil Corp (XOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Quest Diagnostics Inc (DGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esot …
  • Parion Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Parion Sciences Inc (Parion Sciences) is a development stage company that provides research, development and commercialization of treatments to improve patient’s innate mucosal surface defenses. The company’s pipeline products include P-1037, a clinical stage ENaC blocker for pulmonary disea …
  • Saudi Aramco:企業の戦略・SWOT・財務情報
    Saudi Aramco - Strategy, SWOT and Corporate Finance Report Summary Saudi Aramco - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • George Weston Limited (WN):企業の財務・戦略的SWOT分析
    George Weston Limited (WN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Redington (India) Limited (REDINGTON):企業の財務・戦略的SWOT分析
    Redington (India) Limited (REDINGTON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Genextra Spa:製薬・医療:M&Aディール及び事業提携情報
    Summary Genextra SpA (Genextra) is a therapies developing company that discovers and develops therapies for age-related and metabolic diseases. The company develops INT-747 for comb, INT- 777 for metabolic syndrome, mono therapy and diabetes, novel HDAC and HSP90 inhibitors for the treatment of canc …
  • Mahindra & Mahindra Ltd (M&M):企業の財務・戦略的SWOT分析
    Mahindra & Mahindra Ltd (M&M) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Beacon Industries Inc.:企業の戦略・SWOT・財務分析
    Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Fauji Fertilizer Bin Qasim Ltd (FFBL):電力:M&Aディール及び事業提携情報
    Summary Fauji Fertilizer Bin Qasim Ltd (FFBL) is a chemical manufacturing company that manufactures, supplies and markets di ammonium phosphate (DAP) and granular urea. In addition, the company undertakes production and marketing of ammonia and other nitrogenous fertilizers for agricultural applicat …
  • Altice Europe Nv:企業の戦略・SWOT・財務分析
    Altice Europe Nv - Strategy, SWOT and Corporate Finance Report Summary Altice Europe Nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Valvoline Inc (VVV):企業の財務・戦略的SWOT分析
    Valvoline Inc (VVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Coresa Sa:企業の戦略・SWOT・財務分析
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • UGI Corporation:企業の戦略・SWOT・財務情報
    UGI Corporation - Strategy, SWOT and Corporate Finance Report Summary UGI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tragara Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tragara Pharmaceuticals Inc (Tragara Pharmaceuticals) is a pharmaceutical company focused on the clinical and commercial development of its proprietary medicines for the treatment of various cancers. Its lead product candidate TG02, an oral multi-kinase inhibitor facilitates anti-tumor activ …
  • Neuralstem Inc:企業のM&A・事業提携・投資動向
    Neuralstem Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Neuralstem Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • The Broad Institute Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Broadcom Inc (AVGO):企業の財務・戦略的SWOT分析
    Broadcom Inc (AVGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sanofi Genzyme:企業の戦略・SWOT・財務分析
    Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report Summary Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆